Regeneron Pharmaceuticals
REGN
#288
Rank
NZ$132.84 B
Marketcap
NZ$1,253
Share price
-0.12%
Change (1 day)
-2.25%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$4.69 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total debt is NZ$4.69 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Regeneron Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$4.79 B12.2%
2023-12-31NZ$4.27 B0.45%
2022-12-31NZ$4.25 B7.65%
2021-12-31NZ$3.95 B5.79%
2020-12-31NZ$3.73 B252.45%
2019-12-31NZ$1.06 B0.36%
2018-12-31NZ$1.05 B6.63%
2017-12-31NZ$0.99 B42.61%
2016-12-31NZ$0.69 B30.99%
2015-12-31NZ$0.53 B-9.23%
2014-12-31NZ$0.58 B-4.86%
2013-12-31NZ$0.61 B10.45%
2012-12-31NZ$0.55 B-0.38%
2011-12-31NZ$0.55 B169.03%
2010-12-31NZ$0.20 B38.19%
2009-12-31NZ$0.15 B1610.31%
2008-12-31NZ$8.77 M-96.64%
2007-12-31NZ$0.26 B-8.03%
2006-12-31NZ$0.28 B-2.98%
2005-12-31NZ$0.29 B4.4%
2004-12-31NZ$0.28 B-14.79%
2003-12-31NZ$0.32 B-13.99%
2002-12-31NZ$0.38 B-20.82%
2001-12-31NZ$0.48 B7884.05%
2000-12-31NZ$6.04 M-22.89%
1999-12-31NZ$7.84 M-1.56%
1998-12-31NZ$7.96 M-17.41%
1997-12-31NZ$9.65 M-21.63%
1996-12-31NZ$12.31 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
NZ$94.65 B 1,917.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$2.26 B-51.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$11.42 B 143.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.41 B 1,592.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$55.52 B 1,083.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$44.27 B 843.68%๐Ÿ‡ซ๐Ÿ‡ท France